Kim, Y., Lee, S., Lee, Y., Lee, H., Lee, J., & Choi, E. (2018). Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma. J Gynecol Oncol.
シカゴスタイル引用形Kim, Yong-Man, Shin-Wha Lee, Young-Jae Lee, Ha-Young Lee, Jong-Eun Lee, , Eun-Kyung Choi. "Prospective Study of the Efficacy and Utility of TP53 Mutations in Circulating Tumor DNA As a Non-invasive Biomarker of Treatment Response Monitoring in Patients With High-grade Serous Ovarian Carcinoma." J Gynecol Oncol 2018.
MLA引用形式Kim, Yong-Man, et al. "Prospective Study of the Efficacy and Utility of TP53 Mutations in Circulating Tumor DNA As a Non-invasive Biomarker of Treatment Response Monitoring in Patients With High-grade Serous Ovarian Carcinoma." J Gynecol Oncol 2018.